Recalls / Active ingredient / Lamivudine
Lamivudine
1 FDA drug recall involving the active ingredient “Lamivudine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Triumeq (abacavir, dolutegravir, and lamivudine) 600 mg/50 mg/300 mg Tablets 30 Tablets Rx Only NDC 49702-231- | Cardinal Health Inc. |